Crossmark

Emulating Hypothetical Target Trials of the Broad-Spectrum T2 Biologic Dupilumab

Crossref DOI link: https://doi.org/10.1513/AnnalsATS.202403-268LE

Published Online: 2024-07-01

Published Print: 2024-07-01

Update policy: https://doi.org/10.1164/crossmarkpolicies

Authors

Akenroye, Ayobami https://orcid.org/0000-0002-1909-1470
Keet, Corinne
Funding

Funding for this research was provided by:

ALA/ATS/CHEST Foundation Respiratory (Equity Award)

National Institute on Minority Health and Health Disparities (R00MD015767)

Brigham and Women’s Hospital Minority (Faculty Career Development Award)

ALA/ATS/CHEST Foundation Respiratory (Equity Award)

National Institute on Minority Health and Health Disparities (R00MD015767)

Brigham and Women’s Hospital Minority (Faculty Career Development Award)
License Information

Version of Record valid from 2026-01-22
More Information

Publication History

Published: 2024-07-01